0001237899-14-000019.txt : 20140213
0001237899-14-000019.hdr.sgml : 20140213
20140213183213
ACCESSION NUMBER: 0001237899-14-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140212
FILED AS OF DATE: 20140213
DATE AS OF CHANGE: 20140213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAHL NEIL
CENTRAL INDEX KEY: 0001226689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 14608510
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-02-12
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001226689
STAHL NEIL
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Research and Development S
Common Stock
2014-02-12
4
M
0
40000.0
21.25
A
64391
D
Common Stock
2014-02-12
4
F
0
2619.0
324.44
D
61772
D
Common Stock
2014-02-12
4
F
0
20865.0
324.44
D
40907
D
Common Stock
2014-02-12
4
M
0
8000.0
16.8
A
48907
D
Common Stock
2014-02-12
4
F
0
414.0
324.44
D
48493
D
Common Stock
2014-02-12
4
F
0
4234.0
324.44
D
44259
D
Common Stock
2014-02-12
4
M
0
6548.0
16.8
A
50807
D
Common Stock
2014-02-12
4
F
0
339.0
324.44
D
50468
D
Common Stock
2014-02-12
4
F
0
3465.0
324.44
D
47003
D
Common Stock
2014-02-13
4
S
0
1800.0
316.55
D
45203
D
Common Stock
2014-02-13
4
S
0
5360.0
317.58
D
39843
D
Common Stock
2014-02-13
4
S
0
6418.0
318.51
D
33425
D
Common Stock
2014-02-13
4
S
0
3819.0
319.47
D
29606
D
Common Stock
2014-02-13
4
S
0
3575.0
320.6
D
26031
D
Common Stock
2014-02-13
4
S
0
1640.0
321.17
D
24391
D
Common Stock
20000
I
by GRAT
Common Stock
5568
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
16.8
2014-02-12
4
M
0
8000.0
0.0
D
2018-12-17
Common Stock
8000
6548
D
Non-Qualified Stock Option (right to buy)
16.8
2014-02-12
4
M
0
6548.0
0.0
D
2018-12-17
Common Stock
6548
0
D
Non-Qualified Stock Option (right to buy)
21.25
2014-02-12
4
M
0
40000.0
0.0
D
2019-12-18
Common Stock
40000
80295
D
Represents volume-weighted average price of sales of 1,800 shares of Company stock on February 13, 2014 at prices ranging from $316.07 to $316.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price.
Represents volume-weighted average price of sales of 5,360 shares of Company stock on February 13, 2014 at prices ranging from $317.00 to $317.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price.
Represents volume-weighted average price of sales of 6,418 shares of Company stock on February 13, 2014 at prices ranging from $318.00 to $318.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price.
Represents volume-weighted average price of sales of 3,819 shares of Company stock on February 13, 2014 at prices ranging from $319.00 to $319.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price.
Represents volume-weighted average price of sales of 3,575 shares of Company stock on February 13, 2014 at prices ranging from $320.10 to $320.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,640 shares of Company stock on February 13, 2014 at prices ranging from $321.00 to $321.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2014 at each separate price.
The option became exercisable with respect to all shares underlying the option on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
The option became exercisable with respect to all shares underlying the option on December 31, 2012, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2012.
/s/**Neil Stahl
2014-02-13